Instalab

Migratory Locust IgE Test Blood

See whether your immune system reacts to locust proteins, useful for lab workers and anyone considering edible insects.

Should you take a Migratory Locust IgE test?

This test is most useful if any of these apply to you.

Working Around Insects at Your Job
If you handle locusts, crickets, or other insects in a lab, farm, or food facility, this test can reveal whether work symptoms are immune-driven.
Allergic to Shrimp or Dust Mites
Shared proteins mean people with shellfish or mite allergies may quietly react to locust. This test maps that cross-reactivity.
Trying Cricket Flour or Insect Protein
Edible insects are showing up in protein bars, flours, and supplements. If you have any allergy history, check before adding them to your diet.
Unexplained Asthma or Skin Reactions
New respiratory or skin symptoms after insect exposure at work or in your food make locust IgE worth checking.

About Migratory Locust IgE

If you work with locusts in a research lab, raise insects for animal feed, or are curious about eating crickets and other edible insects, your immune system may already be quietly tracking these proteins. This test measures one specific signal of that reaction.

It also matters for people who already have shellfish, dust mite, or other insect allergies. Locust proteins share structural similarities with these allergens, and a positive reading can help explain unexpected symptoms or guide decisions about insect-based foods.

What This Test Measures

This test measures sIgE (allergen-specific immunoglobulin E) directed against proteins from the migratory locust (Locusta migratoria). IgE is an antibody, a Y-shaped protein your immune cells make when they decide a particular substance is a threat. Once IgE for a specific allergen exists in your blood, it sits on the surface of mast cells and basophils, your body's rapid-response immune cells, ready to trigger an allergic reaction the next time that allergen appears.

A positive result means your immune system has been sensitized to locust proteins. Sensitization is not the same as clinical allergy. Many people with detectable sIgE never develop symptoms. The result becomes meaningful when paired with a clear history of reactions, exposure, or symptoms after contact with locusts or related allergens.

Occupational Allergy in Locust Workers

The clearest evidence for locust IgE testing comes from people who handle live insects for a living. In a survey of 57 laboratory workers chronically exposed to migratory locusts, 40.4% had occupational locust allergy based on symptoms and immunologic testing. Rhinitis and skin reactions were the most common complaints.

An earlier study of 35 research-center workers found that all nine symptomatic, currently exposed workers had detectable serum IgE to locust. Antibody binding was higher in exposed, skin-test-positive individuals (mean 12.7%) than in non-exposed or test-negative groups. A specific locust protein called hexamerin-2 (about 70 kilodaltons in size) has been identified as a major allergen, and recombinant hexamerin-2 blocked roughly 60% of IgE binding to crude locust extract in allergic workers.

Reported locust-induced symptoms include asthma, nasal allergy, hives on contact, and atopic dermatitis, mainly in those with heavy occupational exposure. If you work in an insect-rearing facility, a research lab using locusts, or a feed-production setting, this test can help confirm whether respiratory or skin symptoms at work are driven by an immune reaction to locust proteins.

Cross-Reactivity With Other Allergens

Locust IgE rarely shows up in isolation. In a Polish cohort of 6,173 adults tested with an extended sIgE panel, about 6% had sIgE to house cricket, migratory locust, or yellow mealworm. Among those sensitized to yellow mealworm, 63.3% also had IgE to migratory locust and 80.9% to house cricket.

This pattern reflects shared protein families, sometimes called pan-allergens, that appear across insects, shellfish, and dust mites. The most common shared targets include tropomyosins (a muscle protein), NPC2 proteins, and certain digestive enzymes. Roughly 20 to 35% of people positive for yellow mealworm IgE also had IgE to various crustaceans and mollusks like shrimp, crab, and mussel.

If you already have a shellfish, dust mite, or cockroach allergy, you may be more likely to have detectable locust IgE without ever having eaten or handled a locust. This becomes practically relevant as edible insects move into mainstream food products like protein bars, flours, and supplements.

Edible Insects and Food Safety

Insects are increasingly used as a protein source in foods, animal feed, and supplements across Europe, Asia, and North America. For most people, this is a non-issue. For someone with established shellfish or insect allergies, eating cricket-flour pasta or mealworm protein bars can be risky, and locust IgE is one piece of that puzzle.

A laboratory-positive result does not mean you will react to eating locusts or related insects. It indicates your immune system recognizes the protein. Confirming whether that recognition will translate into a real-world reaction usually requires consultation with an allergy specialist, who may consider supervised food challenges or functional tests.

Why a Positive Result Does Not Always Mean Allergy

This is the single most useful point to understand about any allergen-specific IgE test. In large population studies of asymptomatic adults, 31 to 55% had positive sIgE to at least one allergen without ever having symptoms. A high-throughput study of mealworm, locust, and cricket sensitization explicitly noted that sIgE positivity alone cannot define clinical allergy.

What a positive locust IgE tells you is that your immune system has been exposed to locust proteins (or proteins similar enough to cross-react) and has produced antibodies. Whether that translates into asthma, hives, or anaphylaxis depends on factors the blood test cannot capture: total allergen exposure, mast cell sensitivity, and individual immune regulation. The test is most useful when interpreted alongside a clear story of symptoms after exposure.

How It Compares to Standard Allergy Testing

Standard panels (the most common food and inhalant allergy screens) usually do not include migratory locust. If you have a standard panel come back clean, that does not rule out locust sensitization. The two tests measure different things.

Component-resolved diagnostics, which look at specific protein components of an allergen rather than the whole extract, generally have higher specificity than extract-based tests. For peanut, the component Ara h 2 at a cutoff of 0.35 kU/L shows sensitivity around 83% and specificity around 84% in children. No comparable validated cutoffs exist yet for migratory locust, which is why this test is best used as one input alongside symptoms and exposure history.

Tracking Your Trend

A single allergen-specific IgE reading captures a moment in time. Your immune memory can shift with repeated exposure, with avoidance, or after immunotherapy. For someone with confirmed locust allergy who is changing their work environment, or someone with rising shellfish reactions wondering about cross-reactivity, retesting after meaningful exposure changes can show whether the underlying sensitization is intensifying or fading.

A reasonable cadence: get a baseline if you have new exposure, recurrent symptoms, or known cross-reactive allergies. If you change jobs, modify your diet to include or exclude insect proteins, or undergo allergen immunotherapy, retest in 6 to 12 months. Without changes, annual retesting is enough for most people in monitoring scenarios. Single readings should never drive irreversible decisions like dietary elimination or career change without specialist input.

What an Unexpected Result Should Make You Do

A positive locust IgE on its own is not a diagnosis. The right next steps depend on what surrounds the result. If you have symptoms at work or after eating insect-containing products, consult an allergist. They can order a broader insect and invertebrate panel, including house cricket, yellow mealworm, shrimp, dust mite, and cockroach IgE, to map the full pattern.

Component-resolved testing, basophil activation tests (which measure how your immune cells actually respond to allergen in a test tube), or supervised food challenges may be appropriate. If you are asymptomatic but the result was high, the practical step is awareness: know that insect-derived ingredients in food and supplements could provoke a reaction, and review labels accordingly. If your test was triggered by occupational concern, document workplace exposures and discuss respiratory protection with your employer's health team.

When Results Can Be Misleading

A few things can distort a single reading:

  • Recent vigorous exercise: a single bout of intense exercise causes large transient shifts in immune cell counts, with effects normalizing by about 24 hours. While direct effects on locust IgE specifically have not been studied, immune measurements in general can be acutely altered.
  • Cross-reactivity, not true allergy: a positive result driven by tropomyosin from shrimp or dust mite rather than locust-specific proteins. This is technically a true positive, but it changes what the result means for you.
  • Sensitization without symptoms: detectable IgE in someone who has never reacted to locusts and has no exposure. The lab number is real; the clinical relevance may be zero.
  • Lab platform differences: in young children, three common sIgE systems (ImmunoCAP, ISAC microarray, Euroline immunoblot) showed similar overall performance but did not always agree on individual results. Lab-to-lab comparison should be done with the same method.

Who Should Consider This Test

This test is most useful for: people with occupational exposure to locusts or other insects (lab workers, insect farmers, feed-production employees) who have new respiratory or skin symptoms; people with known shellfish, dust mite, or cockroach allergy considering insect-based foods; and people who have had an unexplained allergic reaction after eating products containing edible insect protein.

For the general public with no exposure history and no symptoms, the test is unlikely to provide actionable information. Allergy biomarkers are meant to be interpreted in context, and context starts with a real-world reason to suspect a problem.

What Moves This Biomarker

Evidence-backed interventions that affect your Migratory Locust IgE level

Decrease
Omalizumab (an injectable antibody that binds and neutralizes IgE)
Omalizumab lowers free IgE in your blood and reduces allergic reactions to multiple allergens, though it has not been tested specifically for migratory locust IgE. In a randomized trial of 180 people with multiple food allergies, 16 weeks of omalizumab significantly raised the threshold for reactions to peanut and other common food allergens compared with placebo. The drug binds free IgE and blocks it from triggering allergic reactions, but does not eliminate sensitization itself.
MedicationStrong Evidence
Up & Down
Allergen-specific immunotherapy (gradual exposure to an allergen under medical supervision)
Allergen immunotherapy can shift your immune system away from IgE-driven responses toward tolerance, generally raising allergen-specific IgE transiently before lowering it over months to years. A systematic review and meta-analysis showed immunotherapy can raise reaction thresholds in IgE-mediated food allergy in children, with modest increased risk of serious systemic reactions and substantial increase in minor local reactions. Specific data on migratory locust immunotherapy do not exist; this is the general pattern for IgE-mediated allergies.
MedicationModerate Evidence
Decrease
Reducing occupational exposure to locust proteins (improved ventilation, respiratory protection, leaving an exposed job)
Removing or reducing direct exposure to locust proteins reduces the immune stimulus driving IgE production over time. In studies of laboratory workers handling locusts, those with current heavy exposure had higher locust-specific IgE binding than non-exposed or symptom-free workers. Reducing exposure is the cornerstone of managing occupational allergy in this setting, though precise timelines for IgE decline have not been quantified.
LifestyleModerate Evidence

Frequently Asked Questions

References

11 studies
  1. Wang Y, Zhang Y, Lou H, Wang C, Ni M, Yu D, Zhang L, Kang LJournal of Asthma and Allergy2022
  2. Tee R, Gordon DJ, Hawkins ER, Nunn AJ, Lacey J, Venables K, Cooter R, Mccaffery a, Taylor AJThe Journal of Allergy and Clinical Immunology1988
  3. Majsiak E, Choina M, Gromek W, Wykrota J, Kozłowska D, Swadźba J, Cukrowska B, Kowal KScientific Reports2025
  4. Burge P, Edge G, O'brien I, Harries M, Hawkins R, Pepys JClinical and Experimental Allergy1980